FMP
Resverlogix Corp.
RVX.TO
TSX
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. It is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases. Resverlogix Corp. has a partnership with Eversana Life Science Services, LLC to support the pending launch of the commercialization of apabetalone for Covid-19 in the United States and Canada. The company is headquartered in Calgary, Canada.
0.055 CAD
-0.005 (-9.09%)
About
ceo
Mr. Donald J. McCaffrey
sector
Healthcare
industry
Biotechnology
website
https://www.resverlogix.com
exchange
TSX
Description
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. It is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases. Resverlogix Corp. has a partnership with Eversana Life Science Services, LLC to support the pending launch of the commercialization of apabetalone for Covid-19 in the United States and Canada. The company is headquartered in Calgary, Canada.
CIK
N/A
ISIN
CA76128M1086
CUSIP
76128M108
Address
4820 Richard Road SW
Phone
14032549252
Country
CA
Employee
19
IPO Date
May 7, 2004
Summary
CIK
-
Exchange
TSX
Industry
Biotechnology
Sector
Healthcare
CUSIP
76128M108
ISIN
CA76128M1086
Country
CA
Price
0.06
Beta
0.72
Volume Avg.
25.9k
Market Cap
15.79M
Shares
-
52-Week
0.05-0.15
DCF
-0.03
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.69
P/B
-
Website
https://www.resverlogix.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest RVX.TO News
It looks like there's no news available.
